本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

0.6871
-0.0079-1.14%
盤後0.69240.0053+0.78%16:44 EDT
成交量:6.54萬
成交額:4.51萬
市值:1,001.23萬
市盈率:-0.63
高:0.7000
開:0.7000
低:0.6800
收:0.6950
52周最高:3.12
52周最低:0.6320
股本:1,457.29萬
流通股本:1,457.04萬
量比:0.44
換手率:0.45%
股息:- -
股息率:- -
每股收益(TTM):-1.0863
每股收益(LYR):-1.0863
淨資產收益率:-134.94%
總資產收益率:-53.18%
市淨率:1.84
市盈率(LYR):-0.63

資料載入中...

2025/07/25

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/07/23

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/04/14

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/06

SEC問詢函

Form CORRESP - Correspondence
2024/04/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/03

SEC問詢函

Form CORRESP - Correspondence
2023/09/11

SEC問詢函

Form CORRESP - Correspondence
2023/04/21

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2023/02/08

SEC問詢函

CORRESP [Cover] - Correspondence
2023/01/31

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/03/24

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

SEC問詢函

CORRESP [Cover] - Correspondence